Biologic Versus Conventional Therapies: Comparing Risk of Psoriasis-Associated Comorbidities

Evan Darwin; Mark Lebwohl; George Han

doi:10.36849/JDD.7119

Biologic Versus Conventional Therapies: Comparing Risk of Psoriasis-Associated Comorbidities

Evan Darwin, Mark Lebwohl, George Han

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Abstract

Psoriasis is associated with multiple comorbidities. In this retrospective cohort analysis, we compared the comorbidities in patients who received biologic treatments with those who received conventional treatments. Our data indicates that biologies may be associated with lower rates of comorbidities in comparison to conventional therapy.

Original language	English
Pages (from-to)	621-622
Number of pages	2
Journal	Journal of Drugs in Dermatology
Volume	22
Issue number	6
DOIs	https://doi.org/10.36849/JDD.7119
State	Published - Jun 2023

Access to Document

10.36849/JDD.7119

Cite this

@article{0a3ee6eca5174ed08dc8f0c194b94496,

title = "Biologic Versus Conventional Therapies: Comparing Risk of Psoriasis-Associated Comorbidities",

abstract = "Psoriasis is associated with multiple comorbidities. In this retrospective cohort analysis, we compared the comorbidities in patients who received biologic treatments with those who received conventional treatments. Our data indicates that biologies may be associated with lower rates of comorbidities in comparison to conventional therapy.",

author = "Evan Darwin and Mark Lebwohl and George Han",

year = "2023",

month = jun,

doi = "10.36849/JDD.7119",

language = "English",

volume = "22",

pages = "621--622",

journal = "Journal of Drugs in Dermatology",

issn = "1545-9616",

publisher = "Journal of Drugs in Dermatology",

number = "6",

}

TY - JOUR

T1 - Biologic Versus Conventional Therapies

T2 - Comparing Risk of Psoriasis-Associated Comorbidities

AU - Darwin, Evan

AU - Lebwohl, Mark

AU - Han, George

PY - 2023/6

Y1 - 2023/6

N2 - Psoriasis is associated with multiple comorbidities. In this retrospective cohort analysis, we compared the comorbidities in patients who received biologic treatments with those who received conventional treatments. Our data indicates that biologies may be associated with lower rates of comorbidities in comparison to conventional therapy.

AB - Psoriasis is associated with multiple comorbidities. In this retrospective cohort analysis, we compared the comorbidities in patients who received biologic treatments with those who received conventional treatments. Our data indicates that biologies may be associated with lower rates of comorbidities in comparison to conventional therapy.

UR - http://www.scopus.com/inward/record.url?scp=85160974736&partnerID=8YFLogxK

U2 - 10.36849/JDD.7119

DO - 10.36849/JDD.7119

M3 - Article

C2 - 37276161

AN - SCOPUS:85160974736

SN - 1545-9616

VL - 22

SP - 621

EP - 622

JO - Journal of Drugs in Dermatology

JF - Journal of Drugs in Dermatology

IS - 6

ER -

Biologic Versus Conventional Therapies: Comparing Risk of Psoriasis-Associated Comorbidities

Abstract

Access to Document

Fingerprint

Cite this